Exploring the therapeutic potential of Chinese herbs on comorbid type 2 diabetes mellitus and Parkinson's disease: A mechanistic study
- 12 November 2024
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 338 (Pt 3) , 119095
Abstract
No abstract availableKeywords
This publication has 258 references indexed in Scilit:
- Anti‐inflammatory, antioxidant, and immunomodulatory effects of Berberis vulgaris and its constituent berberine, experimental and clinical, a reviewPhytotherapy Research, 2024
- Isoliquiritigenin inhibits microglia‐mediated neuroinflammation in models of Parkinson's disease via JNK/AKT/NFκB signaling pathwayPhytotherapy Research, 2022
- The Impact of Type 2 Diabetes in Parkinson's DiseaseMovement Disorders, 2022
- Serum Inflammatory Markers and Progression of Nonmotor Symptoms in Early Parkinson's DiseaseMovement Disorders, 2022
- Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and ProgressionMovement Disorders, 2021
- MFG‐E8 reverses microglial‐induced neurotoxic astrocyte (A1) via NF‐κB and PI3K‐Akt pathwaysJournal of Cellular Physiology, 2018
- The role of amyloidogenic proteins as a meeting point of type 2 diabetes and Parkinson's disease pathwaysMovement Disorders, 2017
- Salidroside induces rat mesenchymal stem cells to differentiate into dopaminergic neuronsCell Biology International, 2013
- Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress?Annals of Neurology, 1998
- Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal gangliaAnnals of Neurology, 1994